EBR Systems (EBRCZ) EBIT Margin (2025 - 2026)
EBR Systems' (EBRCZ) quarterly EBIT Margin came in at 684.67% in Q1 2026, up 51.83% quarter-over-quarter from 1421.36% in Q4 2025.
Analysis
EBR Systems (EBRCZ) EBIT Margin (2025 - 2026) Analysis & Trends
EBR Systems has disclosed EBIT Margin across 2 years of filings, most recently posting 684.67% for Q1 2026.
- In Q1 2026, EBIT Margin changed N/A year-over-year to 684.67%; the TTM figure through Mar 2026 stood at 1318.86% (changed N/A YoY), while the FY2025 annual figure was 2850.15%, changed N/A from the prior year.
- EBIT Margin came in at 684.67% for Q1 2026 at EBR Systems, up from 1421.36% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 684.67% in Q1 2026 to a low of 6559.62% in Q2 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | EBR Systems | 10.83 Mn | 10.83 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -684.67% |
| Dec 31, 2025 | -1,421.36% |
| Sep 30, 2025 | -2,320.05% |
| Jun 30, 2025 | -6,559.62% |